Not just another data point - get a picture of his email | CYDY Message Board Posts

CYDY   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  4714 of 5772  at  8/10/2020 12:21:53 PM  by

Kilroy


 In response to msg 4713 by  longpvct88
view thread

Re: Not just another data point - get a picture of his email

Get a grip, people. Trodlevy, which Feuerstein inquires about, got accelerated, conditional approval for TNBC. From the Immunomedics website:

`"TRODELVY (sacituzumab govitecan-hziy) is a Trop-2 directed antibody-drug conjugate indicated for the treatment of adult patients with metastatic triple-negative breast cancer (mTNBC) who have received at least two prior therapies for metastatic disease.

This indication is approved under accelerated approval based on tumor response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials."

I'm not saying Feuerstein's motives are pure, or that it's even his business, but I suggest you look at the basis of your own interest in this case when Leronlimab doesn't have even conditional approval yet.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 1     Views: 132
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
4715 Re: Not just another data point - get a picture of his email Biotech Noobie 7 8/10/2020 12:29:28 PM
4716 Re: Not just another data point - get a picture of his email ArnaTN 1 8/10/2020 12:46:49 PM
4717 Re: Not just another data point - get a picture of his email JBird61 12 8/10/2020 12:48:19 PM






Financial Market Data provided by
.


Loading...